Pharmacy or Superstore? 5 Reasons 'Warehouse Pharmacy' MegaFactory Is Disrupting Korea's Drug Distribution Market
MegaFactory, a warehouse-style pharmacy that launched in Seongnam in June 2025, has expanded to over 40 locations nationwide in less than a year. While consumers are cheering and pharmacist associations are pushing back, the 'Costco of pharmacies' is rapidly reshaping Korea's drug distribution paradigm amid a regulatory vacuum.

Hook: Carts piled high with Tylenol and Impactamin, a queue stretching to the checkout — this isn't a supermarket. It's a pharmacy.
TL;DR
- Korea's first warehouse-style pharmacy, MegaFactory, opened in Seongnam, Gyeonggi Province in June 2025 and has since expanded to over 40 locations nationwide as of March 2026
- Prices 20–30% cheaper than neighborhood pharmacies, with a cart-shopping format that has triggered explosive consumer demand
- All major pharmaceutical companies — Dong-A, Kwangdong, SK Chemicals, GC Pharma — are supplying products; opting out is no longer a viable option
- The Korean Pharmaceutical Association has pushed back over concerns about drug misuse, bulk buying, and inadequate medication counseling, initiating disciplinary proceedings
- A regulatory vacuum persists — once registration requirements are met, even local governments have little legal basis to block openings
1. The Facts: What Is Happening
MegaFactory Pharmacy opened its doors in Seongnam, Gyeonggi Province in June 2025 as the first of its kind in Korea. What sets it apart from conventional pharmacies is its warehouse-style open layout. Shoppers push carts and personally select from over 2,500 types of medicines and health supplements — cold remedies, pain relievers, vitamins — directly off the shelves. It is a complete departure from the traditional model where a pharmacist hands medication over the counter.
- February 2, 2026: Seoul Branch (2nd location) officially opened inside Homeplus, Geumcheon-gu, Seoul
- As of March 2026: Present in 11+ of Korea's 16 metropolitan regions, with 40+ locations open
- In 2025: 1 in every 6 newly opened pharmacies was a large-format pharmacy
- Impactamin at ₩39,000 (29% cheaper than the ₩55,000 neighborhood pharmacy price); average of 20–30% savings on common medications
Korea JoongAng Daily (March 2, 2026) covered the story under the headline "Cheap, convenient — and controversial: Warehouse pharmacies reshape Korea's drug retail market," signaling growing international attention.
2. Why It Spread So Fast
🛒 Consumer Demand Exploded First
"I filled my cart and it came to less than ₩30,000. I was shocked." — A visitor in their 40s (quoted in Korea JoongAng Daily)
In an era of high inflation, even pharmaceuticals have become a 'value-for-money' concern. At a time when fast food feels like a luxury (McDonald's Big Mac Meal: ₩7,600; Burger King Whopper Meal: ₩9,600), MegaFactory's pricing innovation generated an immediate response.
🏭 Pharmaceutical Companies See It as a Channel They Can't Afford to Skip
Reporting reveals that most major pharmaceutical companies — including Dong-A, Kwangdong, SK Chemicals, and GC Pharma — are supplying MegaFactory. One industry insider said: "We can't ignore our relationships with existing pharmacies, but as long as there is consumer demand, this is a channel we can't sit out."
🏬 Large Retailers Like Homeplus and E-Mart See a New Revenue Stream
For both parties, in-store placement inside large retailers is a win-win. Retailers gain foot traffic; pharmacies gain parking, accessibility, and a built-in customer base.
3. Who's Involved
| Stakeholder | Position | Core Argument |
|---|---|---|
| Consumers | Strongly supportive | Better prices, more choice, greater accessibility |
| MegaFactory | Expanding aggressively | Licensed pharmacists on-site; medication counseling is provided |
| Major pharma companies | Supplying products | Can't afford to opt out of a high-demand channel |
| Korean Pharmaceutical Association | Strongly opposed | Risks of misuse, bulk hoarding, and inadequate counseling |
| Neighborhood pharmacies | Facing existential threat | Cannot compete on price; some already closing |
| Government / local authorities | Still deliberating on regulation | Difficult to block openings once registration requirements are met |
The Korean Pharmaceutical Association has focused attention on public health risks — including the possibility of bulk purchases of pseudoephedrine-containing products (a precursor to narcotics) — and has initiated disciplinary proceedings against pharmacists operating warehouse-style pharmacies. Members of the Geumcheon-gu branch held a picket protest at their general assembly, issuing a statement that "medicine is not a distribution commodity — it is a matter of national health that must be managed."
An OhmyNews field report (February 2, 2026) documented the closure of a small pharmacy that had operated for 14 years on the same floor just before a new MegaFactory location opened.
4. Outlook: How Long Will This Last?
Under current law, there are no special restrictions on the size or layout of a pharmacy opened by a licensed pharmacist. The Ministry of Health and Welfare has stated it is "difficult to identify violations of current law," but if pressure from the National Assembly and pharmaceutical associations intensifies, formal legislative regulation could follow.
- Short-term (by mid-2026): MegaFactory projected to grow to 60–80 locations (official expansion plans announced)
- Medium-term (2026–2027): Possible National Assembly bill to amend the Pharmaceutical Affairs Act — discussions on mandatory counseling requirements and purchase quantity limits
- Long-term: Will the format converge toward a U.S.-style CVS/Walgreens chain model, or will Korean-style regulation put on the brakes? A true inflection point is approaching.
MegaFactory's head pharmacist Jung Du-seon stated: "Given consumer response, the timeline for store expansion may be brought forward sooner than we expected."
5. Secondary Issues and Derivative Debates
- Longevity estimate: Long-term issue — regulatory debate has only just begun while the expansion pace is accelerating
- Drug misuse risk: Bulk purchasing of pseudoephedrine (cold medicine ingredient) and codeine-containing products is possible, raising concerns about gaps in narcotics precursor management
- Collapse of the neighborhood pharmacy ecosystem: Declining profitability accelerating closures → a paradox where communities with lower accessibility may actually end up with fewer pharmacies
- Franchise controversy: MegaFactory completed franchise business registration in January 2026 — a potential starting point for the corporatization of pharmacies
- Investment frenzy: Large retailers and shopping malls are eyeing rental income from pharmacy tenants, raising concerns about real estate speculation
✅ Key Checklist
References
- Korea JoongAng Daily — Cheap, convenient — and controversial (March 2, 2026)
- Hankyung — "The medicine that used to cost over ₩50,000..." Why Seoul's new warehouse pharmacy is causing a stir (February 5, 2026)
- OhmyNews — "It's the shop I guarded for 14 years..." What happened before the warehouse pharmacy arrived (February 2, 2026)
- Seoul Economy — 'Ex-Daiso crowd' buzzing as the 'pharmacy Daiso' lands in Seoul (January 2026)
- SentV — The 'warehouse pharmacy' era has arrived, but the law is still stuck in the past (February 26, 2026)
- Korea Daily — Cart full of medicine and still under ₩30,000 (March 1, 2026)
- The Straits Times — Pharmacists in South Korea flag uncontrolled sales